Skip to main content

Select Drug Profiles

FDA Approvals, Select Drug Profiles

Welireg FDA Approved for 3 Tumor Types Associated with von Hippel-Lindau Disease

FDA Approvals, Select Drug Profiles

Jakafi a New Treatment Option for Chronic Graft-versus-Host Disease

FDA Approvals, Select Drug Profiles

Rezurock Novel Oral Therapy FDA Approved for Chronic Graft-versus-Host Disease

FDA Approvals, Select Drug Profiles

Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer

FDA Approvals, Select Drug Profiles

Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer

FDA Approvals, Select Drug Profiles

Trodelvy Receives New Indication for Advanced Urothelial Cancer

FDA Approvals, Select Drug Profiles

Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma

FDA Approvals, Select Drug Profiles

FDA Alert: Pepaxto (Melphalan Flufenamide) Associated with Increased Risk of Death in Postmarketing Clinical Trial

FDA Approvals, Select Drug Profiles

Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker

FDA Approvals, Select Drug Profiles

Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations

1
2
3
4

Page 1 of 13
Results 1 - 10 of 121